Marietta Olaivar Lomboy
Adult Health · Perry, GANPI 1699786327
Payments from drug & device makers
Across 203 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$626
- Novo Nordisk$413
- Lilly USA, LLC$379
- Bayer$305
- AstraZeneca$269
- Pfizer$180
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,962100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $626 |
| Novo Nordisk | 20 | $413 |
| Lilly USA, LLC | 24 | $379 |
| Bayer | 15 | $305 |
| AstraZeneca | 16 | $269 |
| Pfizer | 9 | $180 |
| AbbVie | 9 | $170 |
| Novartis | 9 | $163 |
| Biohaven Pharmaceuticals, Inc. | 1 | $135 |
| GSK | 6 | $123 |
| Johnson & Johnson | 7 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Intuitive Surgical | 1 | $95 |
| Dexcom, Inc. | 5 | $90 |
| Boehringer Ingelheim | 4 | $82 |
| Verity Pharmaceuticals Inc. | 4 | $80 |
| Sanofi Pasteur Inc. | 4 | $78 |
| Merck | 4 | $77 |
| Eisai Inc. | 3 | $63 |
| Exact Sciences | 3 | $49 |
| Phadia US Inc. | 2 | $45 |
| Edwards Lifesciences | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Halozyme Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$135
- EVENITY$125
How this compares
$3,962 in reported general payments places this provider in the 85th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 167 | $222,230 |
| JardianceEmpagliflozin | 160 | $210,514 |
| EliquisApixaban | 137 | $131,620 |
| OzempicSemaglutide | 86 | $111,285 |
| TrulicityDulaglutide | 46 | $91,379 |
| FarxigaDapagliflozin Propanediol | 74 | $60,119 |
| JanuviaSitagliptin Phosphate | 46 | $48,326 |
| XareltoRivaroxaban | 31 | $34,593 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $34,259 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $27,818 |
| Repatha SyringeEvolocumab | 20 | $21,216 |
| LinzessLinaclotide | 20 | $19,148 |
| Repatha SureclickEvolocumab | 28 | $16,854 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $14,964 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $13,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $379 | $313,610213 claims |
| Boehringer IngelheimJardiance | $82 | $210,514160 claims |
| PfizerEliquis | $180 | $131,620137 claims |
| Novo NordiskOzempic | $413 | $111,28586 claims |
| AstraZenecaFarxiga, Brilinta | $269 | $72,40690 claims |
| MerckJanuvia, Janumet, Janumet Xr | $77 | $72,30975 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $123 | $49,90766 claims |
| Johnson & JohnsonXarelto | $119 | $34,59331 claims |
| AbbVieLinzess, Synthroid | $170 | $22,78267 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 577 adult health providers in Georgia.
Other adult health in Perry
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
- Jennifer SheldonMacon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.